Takeda Pharmaceutical Co., Ltd. (TKPHF)
43.15
0.00 (0.00%)
USD |
OTCM |
Nov 16, 16:00
Takeda Pharmaceutical Enterprise Value : 95.39B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 95.39B |
| November 13, 2026 | 95.39B |
| November 12, 2026 | 95.39B |
| November 11, 2026 | 93.10B |
| November 10, 2026 | 93.10B |
| November 09, 2026 | 94.78B |
| November 06, 2026 | 94.12B |
| November 05, 2026 | 93.31B |
| November 04, 2026 | 93.31B |
| November 03, 2026 | 91.81B |
| November 02, 2026 | 92.10B |
| October 30, 2026 | 93.55B |
| October 29, 2026 | 87.12B |
| October 28, 2026 | 87.12B |
| October 27, 2026 | 92.20B |
| October 26, 2026 | 92.31B |
| October 23, 2026 | 92.31B |
| October 22, 2026 | 90.04B |
| October 21, 2026 | 90.04B |
| October 20, 2026 | 90.25B |
| October 19, 2026 | 88.76B |
| October 16, 2026 | 88.18B |
| October 15, 2026 | 88.18B |
| October 14, 2026 | 80.54B |
| October 13, 2026 | 80.54B |
| Date | Value |
|---|---|
| October 12, 2026 | 80.54B |
| October 09, 2026 | 80.54B |
| October 08, 2026 | 80.54B |
| October 07, 2026 | 80.54B |
| October 06, 2026 | 80.54B |
| October 05, 2026 | 83.57B |
| October 02, 2026 | 85.21B |
| October 01, 2026 | 85.17B |
| September 30, 2026 | 85.57B |
| September 29, 2026 | 86.04B |
| September 28, 2026 | 86.04B |
| September 25, 2026 | 86.04B |
| September 24, 2026 | 86.04B |
| September 23, 2026 | 87.62B |
| September 22, 2026 | 87.62B |
| September 21, 2026 | 87.62B |
| September 18, 2026 | 87.62B |
| September 17, 2026 | 87.62B |
| September 16, 2026 | 84.76B |
| September 15, 2026 | 84.76B |
| September 14, 2026 | 84.76B |
| September 11, 2026 | 84.76B |
| September 10, 2026 | 83.41B |
| September 09, 2026 | 84.66B |
| September 08, 2026 | 83.57B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Daiichi Sankyo Co., Ltd. | 31.69B |
| Eisai Co., Ltd. | 9.066B |
| Chugai Pharmaceutical Co., Ltd. | 70.06B |
| Santen Pharmaceutical Co., Ltd. | 3.800B |
| Ono Pharmaceutical Co., Ltd. | 6.348B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.209B |
| Revenue (Quarterly) | 7.454B |
| Total Expenses (Quarterly) | 6.246B |
| EPS Diluted (Quarterly) | 0.7471 |
| Gross Profit Margin (Quarterly) | 57.91% |
| Profit Margin (Quarterly) | 16.21% |
| Earnings Yield | 0.29% |
| Operating Earnings Yield | 7.73% |
| Normalized Earnings Yield | 1.018 |